Medication Requirements for Disease Control Predict the Prognosis of Chronic Urticaria.
作者信息
Choi Jeong Hee
机构信息
Department of Pulmonology and Allergy, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
Allergy and Clinical Immunology Research Center, Hallym University College of Medicine, Chuncheon, Korea.
出版信息
Allergy Asthma Immunol Res. 2021 May;13(3):357-359. doi: 10.4168/aair.2021.13.3.357.
Abstract
摘要
相似文献
1
Medication Requirements for Disease Control Predict the Prognosis of Chronic Urticaria.疾病控制的药物需求可预测慢性荨麻疹的预后。
Allergy Asthma Immunol Res. 2021 May;13(3):357-359. doi: 10.4168/aair.2021.13.3.357.
2
Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation.羟氯喹治疗对慢性荨麻疹的影响：慢性自身免疫性荨麻疹研究与评估
Intern Med J. 2004 Apr;34(4):182-6. doi: 10.1111/j.1444-0903.2004.00532.x.
3
Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine.117 例常规剂量抗组胺药物治疗未控制的慢性自发性荨麻疹患者的预后。
Allergy. 2013 Feb;68(2):229-35. doi: 10.1111/all.12078. Epub 2012 Dec 4.
4
A study of treatment adherence and quality of life among adults with chronic urticaria in Singapore.新加坡慢性荨麻疹成人患者治疗依从性与生活质量的研究。
Asia Pac Allergy. 2015 Oct;5(4):197-202. doi: 10.5415/apallergy.2015.5.4.197. Epub 2015 Oct 28.
5
Combined differentiated therapy in patients with urticaria.
Wiad Lek. 2019;72(4):589-594.
6
Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment.慢性自发性荨麻疹的临床特征可预测疾病预后和对标准治疗的反应性。
Acta Derm Venereol. 2018 Jul 11;98(7):641-647. doi: 10.2340/00015555-2941.
7
The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre.在一家三级转诊中心就诊的慢性荨麻疹和血管性水肿患者的自然病史。
Br J Dermatol. 2002 Jan;146(1):110-3. doi: 10.1046/j.1365-2133.2002.04582.x.
8
The predictive factors for remission of chronic spontaneous urticaria in childhood: Outcome from a prospective study.儿童慢性自发性荨麻疹缓解的预测因素：一项前瞻性研究的结果
Allergol Immunopathol (Madr). 2016 Nov-Dec;44(6):537-541. doi: 10.1016/j.aller.2016.04.011. Epub 2016 Jul 28.
9
Chronic urticaria phenotypes: clinical differences regarding triggers, activity, prognosis and therapeutic response.慢性荨麻疹表型：关于诱因、活动度、预后和治疗反应的临床差异。
Eur J Dermatol. 2019 Dec 1;29(6):627-635. doi: 10.1684/ejd.2019.3674.
10
Chronic inducible urticaria: confirmation through challenge tests and response to treatment.慢性诱导性荨麻疹：通过激发试验确诊及对治疗的反应
Einstein (Sao Paulo). 2020;18:eAO5175. doi: 10.31744/einstein_journal/2020ao5175. Epub 2020 Jul 10.
引用本文的文献
1
Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines.二线治疗对标准剂量抗组胺药难治性慢性荨麻疹的疗效
Allergy Asthma Immunol Res. 2023 Jul;15(4):496-511. doi: 10.4168/aair.2023.15.4.496. Epub 2023 Mar 7.
2
Sex, Allergic Diseases and Omalizumab.性别、过敏性疾病与奥马珠单抗
Biomedicines. 2022 Jan 29;10(2):328. doi: 10.3390/biomedicines10020328.
本文引用的文献
1
Clustering the Clinical Course of Chronic Urticaria Using a Longitudinal Database: Effects on Urticaria Remission.利用纵向数据库对慢性荨麻疹的临床病程进行聚类分析：对荨麻疹缓解的影响。
Allergy Asthma Immunol Res. 2021 May;13(3):390-403. doi: 10.4168/aair.2021.13.3.390.
2
The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria.韩国成人及儿童慢性自发性荨麻疹的KAAACI/KDA循证实践指南：第2部分。H1抗组胺药难治性慢性荨麻疹的管理。
Allergy Asthma Immunol Res. 2020 Sep;12(5):750-770. doi: 10.4168/aair.2020.12.5.750.
3
Serum transglutaminase 2 activity as a potential biomarker of disease severity and response to omalizumab in chronic spontaneous urticaria.血清转谷氨酰胺酶2活性作为慢性自发性荨麻疹疾病严重程度及对奥马珠单抗反应的潜在生物标志物。
Allergol Int. 2020 Apr;69(2):304-306. doi: 10.1016/j.alit.2019.10.009. Epub 2019 Nov 23.
4
Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab.总IgE水平与慢性自发性荨麻疹患者对奥马珠单抗的反应相关。
Allergy. 2018 Dec;73(12):2406-2408. doi: 10.1111/all.13586. Epub 2018 Sep 25.
5
Emerging Biomarkers and Therapeutic Pipelines for Chronic Spontaneous Urticaria.慢性自发性荨麻疹的新兴生物标志物和治疗管道。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1108-1117. doi: 10.1016/j.jaip.2018.02.024.
6
Natural course of new-onset urticaria: Results of a 10-year follow-up, nationwide, population-based study.新发荨麻疹的自然病程：一项基于人群的全国性、10 年随访研究结果。
Allergol Int. 2019 Jan;68(1):52-58. doi: 10.1016/j.alit.2018.05.011. Epub 2018 Jun 23.
7
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.欧洲过敏研究学会/过敏标准委员会/欧洲皮肤病学会/世界变态反应组织荨麻疹指南：定义、分类、诊断和管理。
Allergy. 2018 Jul;73(7):1393-1414. doi: 10.1111/all.13397.
8
Epidemiology of Chronic Urticaria in Korea Using the Korean Health Insurance Database, 2010-2014.利用韩国健康保险数据库对2010 - 2014年韩国慢性荨麻疹的流行病学研究
Allergy Asthma Immunol Res. 2017 Sep;9(5):438-445. doi: 10.4168/aair.2017.9.5.438.
9
Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria.慢性自发性荨麻疹成年患者特定疾病的生活质量损害
Korean J Intern Med. 2018 Jan;33(1):185-192. doi: 10.3904/kjim.2015.195. Epub 2016 Jun 1.
10
Updosing nonsedating antihistamines in patients with chronic spontaneous urticaria: a systematic review and meta-analysis.慢性自发性荨麻疹患者非镇静性抗组胺药加量治疗：系统评价和荟萃分析。
Br J Dermatol. 2016 Dec;175(6):1153-1165. doi: 10.1111/bjd.14768. Epub 2016 Oct 19.
Zotero 插件